|
1
|
Scheff SW and Price DA: Synaptic pathology
in Alzheimer’s disease: a review of ultrastructural studies.
Neurobiol Aging. 24:1029–1046. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Serý O, Povová J, Míšek I, Pešák L and
Janout V: Molecular mechanisms of neuropathological changes in
Alzheimer’s disease: a review. Folia Neuropathol. 51:1–9. 2013.
View Article : Google Scholar
|
|
3
|
Cummings JL, Vinters HV, Cole GM and
Khachaturian ZS: Alzheimer’s disease: etiologies, pathophysiology,
cognitive reserve, and treatment opportunities. Neurology.
51:S2–S17. 1998. View Article : Google Scholar
|
|
4
|
Bredesen DE and John V: Next generation
therapeutics for Alzheimer’s disease. EMBO Mol Med. 2013.
View Article : Google Scholar
|
|
5
|
Ryan TM, Caine J, Mertens HD, et al:
Ammonium hydroxide treatment of Abeta produces an aggregate free
solution suitable for biophysical and cell culture
characterization. Peer J. 1:e732013. View
Article : Google Scholar
|
|
6
|
Aloe L, Rocco ML, Bianchi P and Manni L:
Nerve growth factor: from the early discoveries to the potential
clinical use. J Transl Med. 10:2392012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brady R and Weinman J: Adherence to
cholinesterase inhibitors in Alzheimer’s disease: a review. Dement
Geriatr Cogn Disord. 35:351–363. 2013. View Article : Google Scholar
|
|
8
|
Chorsky RL, Yaghmai F, Hill WD and Stopa
EG: Alzheimer’s disease: a review concerning immune response and
microischemia. Med Hypotheses. 56:124–127. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reale M, Greig NH and Kamal MA: Peripheral
chemo-cytokine profiles in Alzheimer’s and Parkinson’s diseases.
Mini Rev Med Chem. 9:1229–1241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maguire-Zeiss KA and Federoff HJ:
Immune-directed gene therapeutic development for Alzheimer’s,
prion, and Parkinson’s diseases. J Neuroimmune Pharmacol.
4:298–308. 2009. View Article : Google Scholar
|
|
11
|
Wiese S, Karus M and Faissner A:
Astrocytes as a source for extracellular matrix molecules and
cytokines. Front Pharmacol. 3:1202012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Latz E, Xiao TS and Stutz A: Activation
and regulation of the inflammasomes. Nat Rev Immunol. 13:397–411.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rubio-Perez JM and Morillas-Ruiz JM: A
review: inflammatory process in Alzheimer’s disease, role of
cytokines. ScientificWorldJournal. 2012:7563572012. View Article : Google Scholar
|
|
14
|
Di Bona D, Plaia A, Vasto S, et al:
Association between the interleukin-1beta polymorphisms and
Alzheimer’s disease: a systematic review and meta-analysis. Brain
Res Rev. 59:155–163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Forlenza OV, Diniz BS, Talib LL, et al:
Increased serum IL-1beta level in Alzheimer’s disease and mild
cognitive impairment. Dement Geriatr Cogn Disord. 28:507–512. 2009.
View Article : Google Scholar
|
|
16
|
Hamajima N and Yuasa H: Genetic
polymorphisms related to interleukin-1 beta production and disease
risk. Nihon Koshu Eisei Zasshi. 50:194–207. 2003.(In Japanese).
PubMed/NCBI
|
|
17
|
Mitroulis I, Skendros P and Ritis K:
Targeting IL-1beta in disease; the expanding role of NLRP3
inflammasome. Eur J Intern Med. 21:157–163. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Del Bo R, Angeretti N, Lucca E, De Simoni
MG and Forloni G: Reciprocal control of inflammatory cytokines,
IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci
Lett. 188:70–74. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Blume AJ and Vitek MP: Focusing on
IL-1-promotion of beta-amyloid precursor protein synthesis as an
early event in Alzheimer’s disease. Neurobiol Aging. 10:406–408;
discussion 412–404. 1989. View Article : Google Scholar
|
|
20
|
Shannon P, Markiel A, Ozier O, et al:
Cytoscape: a software environment for integrated models of
biomolecular interaction networks. Genome Res. 13:2498–2504. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vertommen A, Møller AL, Cordewener JH, et
al: A workflow for peptide-based proteomics in a poorly sequenced
plant: a case study on the plasma membrane proteome of banana. J
Proteomics. 74:1218–1229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pahl MC, Derr K, Gäbel G, et al: MicroRNA
expression signature in human abdominal aortic aneurysms. BMC Med
Genomics. 5:252012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ogata H, Goto S, Fujibuchi W and Kanehisa
M: Computation with the KEGG pathway database. Biosystems.
47:119–128. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aoki-Kinoshita KF and Kanehisa M: Gene
annotation and pathway mapping in KEGG. Methods Mol Biol.
396:71–91. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu L, Aboud O, Jones RA, Mrak RE, Griffin
WS and Barger SW: Apolipoprotein E expression is elevated by
interleukin 1 and other interleukin 1-induced factors. J
Neuroinflammation. 8:1752011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao J, O’Connor T and Vassar R: The
contribution of activated astrocytes to Abeta production:
implications for Alzheimer’s disease pathogenesis. J
Neuroinflammation. 8:1502011. View Article : Google Scholar
|
|
27
|
He FQ, Qiu BY, Zhang XH, et al:
Tetrandrine attenuates spatial memory impairment and hippocampal
neuroinflammation via inhibiting NF-kappaB activation in a rat
model of Alzheimer’s disease induced by amyloid-beta(1–42). Brain
Res. 1384:89–96. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Serrano-Pozo A, Muzikansky A, Gómez-Isla
T, et al: Differential relationships of reactive astrocytes and
microglia to fibrillar amyloid deposits in Alzheimer disease. J
Neuropathol Exp Neuro. 72:462–471. 2013. View Article : Google Scholar
|
|
29
|
Palm R, Ayala-Fontanez N, Garcia Y, et al:
Neuroendocrinology-based therapy for Alzheimer’s disease.
Biofactors. 38:123–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Henderson VW and Rocca WA: Estrogens and
Alzheimer disease risk: is there a window of opportunity?
Neurology. 79:1840–1841. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aloe L, Rocco ML, Bianchi P and Manni L:
Nerve growth factor: from the early discoveries to the potential
clinical use. Journal of Translational Medicine. 10:2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Di Bona D, Plaia A, Vasto S, et al:
Association between the interleukin-1 beta polymorphisms and
Alzheimer’s disease: A systematic review and meta-analysis. Brain
Research Reviews. 59:155–163. 2008. View Article : Google Scholar
|
|
33
|
Azizi G and Mirshafiey A: The potential
role of proinflammatory and antiinflammatory cytokines in Alzheimer
disease pathogenesis. Immunopharmacology and Immunotoxicology.
34:881–895. 2012. View Article : Google Scholar : PubMed/NCBI
|
